High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma.

Tatsuaki WatanabeTomoko HosakaKaori Ohmori-MatsudaYasuhiro SuzukiHirotoshi SuzukiHiroshi YabukiYasushi MatsudaMasafumi NodaAkira SakuradaYoshinori OkadaYasufumi Sato

Published in: Health science reports (2018)

The present analysis suggests that high preoperative plasma VASH1 concentration is associated with better prognosis in patients with NSCLC. We propose preoperative VASH1 level as a biomarker for the prognosis of patients with non-small cell lung carcinoma.

Keyphrases

patients undergoing
single cell
cell therapy
small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
brain metastases